1.Memory Functions in Schizophrenic Patients.
Journal of Korean Neuropsychiatric Association 2004;43(4):407-414
OBJECTIVES: The purpose of this study was to investigate memory functions in schizophrenic patients. METHODS: The participants were 45 schizophrenic patients and 27 normal controls. The Rey-Kim Memory Test (RKMT) was used as the testing instrument. RESULTS: 1) Schizophrenic patients showed a significantly lower Memory Quotient (MQ) compared with control participants. Their memory impairment was more severe relative to their intelligence impairment. 2) Memory deficits in schizophrenic patients were most pronounced in retrieval phase compared with encoding or retention phase. 3) Both verbal and visual memory were impaired in schizophrenic patients. 4) There were qualitative as well as quantitative individual differences in memory functions among schizophrenic patients. CONCLUSION: Memory impairment in schizophrenia represents a selective cognitive deficit. Its clinical presentation is similar to 'frontal amnesia' in that retrieval deficit is most pronounced.
Humans
;
Individuality
;
Intelligence
;
Memory Disorders
;
Memory*
;
Schizophrenia
2.Severity of Coronary Artery Disease and Visceral Fat Obesity.
Jeongkee SEO ; Dong Soo KIM ; Hyuck Moon KWON ; Yangsoo JANG ; Hyun Seung KIM ; Hongkeun CHO ; Eunyoung CHO ; Jongho LEE
Korean Circulation Journal 1998;28(7):1176-1184
BACKGROUND: The visceral fat obesity is known to be associated with coronary artery disease. We investigated the relation between visceral fat obesity and the severity of coronary artery disease by angiography. METHODS: The coronary artery disease (CAD) group included 54 angina patients (43 men and 11 women) with angiographically demonstrated coronary artery disease. The control group included angiographically normal 28 controls (15 men and 13 women). The subjects with hypertension, non-insulin dependent diabetes mellitus (NIDDM) and taking any medication known to affect the insulin sensitivity were excluded. We measured the visceral fat area, abdominal subcutaneous fat area, thigh muscle area and the thigh fat area with computed tomography (CT) in both groups. We measured the plasma lipid profile, fasting plasma insulin and glucose level in both groups. RESULTS: There were no differences in the age, sex ratio and body mass index (BMI) between both groups. Total cholesterol and triglyceride increased in CAD group significantly (p<0.05, p<0.001). The HDL cholesterol decreased in CAD group. But there was no statistical significance (p=0.056). The fasting insulin increased in CAD group significantly (p<0.001). There were significant differences between CAD group and the control group in the visceral fat area (117.8+/-34.4 cm2vs. 85.5+/-17.6 cm2, p<0.001), thigh fat area (50.0+/-22.3 cm2vs. 65.8+/-12.9 cm2, p<0.001), visceral fat to abdominal subcutaneous fat area ratio (VS ratio:0.81+/-0.31 vs. 0.51+/-0.15, p<0.001) and the visceral fat to thigh fat area ratio (VSFTF ratio:2.72+/-1.24 vs. 1.34+/-0.35, p<0.001). In the male subgroup (CAD:43, control:15), triglyceride and fasting insulin increased in CAD group significantly (p<0.001). The visceral fat area, VS ratio, and VSFTF ratio increased in CAD group significantly (P<0.001) The thigh fat area decreased in CAD group significantly (P<0.001). In the female subgroup (CAD:11, control:13), fasting insulin and visceral fat area increased in CAD group significantly (p<0.001, p<0.05). Multiple logistic regression analysis revealed that VSFTF ratio, fasting insulin and the HDL cholesterol were independent associated factors of coronary artery disease. In comparison with normal control, one-vessel disease and multi-vessel disease (two vessel and three vessel), there were significant differences between groups in fasting insulin, triglyceride, visceral fat area, thigh fat area, VS ratio, VSFTF ratio. In Turkey's HSD Post Hoc test, however, there were no significant differences between one-vessel disease and multi-vessel disease. CONCLUSION: We observed significant increases in the visceral fat area, VS ratio and VSFTF ratio and decrease in thigh fat area in angiographically demonstrated CAD group compared with age, BMI matched angiographically normal control. But we did not observed any relation between the visceral fat area and the severity of coronary disease by angiography.
Angiography
;
Body Mass Index
;
Cholesterol
;
Cholesterol, HDL
;
Coronary Artery Disease*
;
Coronary Disease
;
Coronary Vessels*
;
Diabetes Mellitus
;
Fasting
;
Female
;
Glucose
;
Humans
;
Hypertension
;
Insulin
;
Insulin Resistance
;
Intra-Abdominal Fat*
;
Logistic Models
;
Male
;
Obesity*
;
Plasma
;
Sex Ratio
;
Subcutaneous Fat, Abdominal
;
Thigh
;
Triglycerides
3.Insulin Resistance as an Associated Factor of Essential Hypertension in Korean.
Hongkeun CHO ; Choongwon GOH ; Sung Soon KIM ; Hyun Chul LEE ; Kap Bum HUH ; Hae Kyung CHUNG ; Heesun KIM ; Jongho LEE
Korean Circulation Journal 1996;26(5):1020-1029
BACKGROUND: The insulin resistance is reported as the independent risk factor of the DM and the ischemic heart disease. The association between the insulin resistance and the essential hypertension was reported at the various countries and races. We performed this study to know if the hypertensive patients show the increased insulin resistance than that of the normotensive persons and factors that influence the insulin resistance and the blood pressure. METHODS: The serum lipid profiles, OGTT, body habitus measurement and abdominal CT at umbilical level were performed in 24 hypertensive patients(male : 10, female : 14) and 45 normotensive persons(male : 19, female : 26) who showed the same distributions of age, sex, weight and body mass index(BMI). RESULTS: The average age of the hypertensive group was 49.1+/-7.9 years, and that of the normotensive group was 46.1+/-7.6 years(p>0.05). The average blood pressure of the hypertensive group was 152.2+/-14.2/98.4+/-6.4mmHg and that of the normotensive group was 116.8+/-9.4/78.2+/-49.mmHg(p<0.001). The hypertensive group had significantly higher area under curve(AUC) of glucose(246.8+/-30.4 Vs 219.2+/-32.2mg/dL.hr) and AUC of insulin(88.9+/-38.2 Vs 69.6+/-34.2microU/mL.hr) than the normotensive group(p<0.05), while there were no differences in the age, sex, weight, body mass index(BMI) and waist to hip ratio(WHR) between two groups. They had nodifferences in lipid profile and plasma renin activity. In CT assessment, the hypertensive group had significantly higher visceral fat to thigh muscle area ratio(VSFTM ratio)(0.61+/-0.29 Vs 0.47+/-0.20) and visceral fat to thigh muscle and fat area ratio(VSFTMF ratio)(0.27+/-0.10 Vs 0.22+/-0.13)(p<0.05), while they had same degree of visceral fat to subcutaneous fat area(VS) ratio and visceral fat area. The visceral fat area, VSFTM ratio, VS ratio, visceral fat area to thigh fat area ratio(VSFTF ratio) were positively correlated with AUC of insulin and AUC of glucose ordinary(p<0.05). After adjustment for plasma insulin, AUC of insulin, VS ratio, VSFTM ratio, age and BMI, the AUC of glucose was positively correlated with the diastolic blood pressure(R square=0.19, p <0.05) and the AUC of glucose and WTR were positively correlated with the systolic blood pressure(R square=0.26, p<0.05). THe subgroup over the 75 percentile of AUC of glucose, AUC of insulin and VSFTM ratio in study population had significantly higher odds ratio of the hypertension(OR of AUC of glusose : 5.8, OR of AUC of insulin : 3.2, OR of VSFTM ratio : 4.5, p<0.05). CONCLUSION: These results suggest that the insulin resistance is more prevalent in the hypertensive patients and associated with the hypertension.
Area Under Curve
;
Blood Pressure
;
Body Weight
;
Continental Population Groups
;
Female
;
Glucose
;
Glucose Tolerance Test
;
Hip
;
Humans
;
Hypertension*
;
Insulin Resistance*
;
Insulin*
;
Intra-Abdominal Fat
;
Myocardial Ischemia
;
Odds Ratio
;
Plasma
;
Renin
;
Risk Factors
;
Subcutaneous Fat
;
Thigh
;
Tomography, X-Ray Computed
5.Relationships between Psychotic Symptoms and Cognitive Functions in Schizophrenic Patients.
Journal of the Korean Society of Biological Psychiatry 2007;14(2):122-128
OBJECTIVES: The aim of this study was to investigate relationships between psychotic symptoms and cognitive functions in schizophrenia. METHODS: The study group was composed of 36 schizophrenic patients. Positive, negative, and disorganization symptoms were assessed using the PANSS. Verbal, visuospatial, attention, memory, and executive functions were assessed using a battery of cognitive tests. RESULTS: Correlation analysis between symptom vs. cognitive measures showed that (a) positive symptoms were significantly correlated with no cognitive measures, (b) negative symptoms were significantly correlated with all cognitive measures, and (c) disorganization symptoms were significantly correlated with executive and memory measures. Correlation analyses between symptom vs. cognitive factors showed that negative-disorganization factor is significantly correlated with executive-memory factor. CONCLUSION: Significant relationships were confined mostly to frontal symptoms vs. frontal cognitive functions. Thus, the relationships may be mediated mainly by variations in severity of frontal pathology among patients.
Executive Function
;
Fibrinogen
;
Humans
;
Memory
;
Pathology
;
Schizophrenia
6.Immediate Results of AVE Micro-II Stent.
Jong Cheol RYU ; Yangsoo JANG ; Keun Young KIM ; Seung Hwan LEE ; Jong Huyn KIM ; Dong Woon JEON ; Won Heum SHIM ; Seung Yun CHO ; Hongkeun CHO
Korean Circulation Journal 1997;27(5):532-540
BACKGROUND: Several kinds of stents have shown their safety and efficacy to treat acute or subacute closure after balloon angioplasty as well as to reduce restenosis rate. However, one of the limitations of stents is difficult to deploy especially in tortuos vessels, lesions at a bend, and distal to previously deployed stents. The Micro stent II, which was one of the most recently developed stents, ia a rapid-exchage balloon expandable stainless steel stent with a zigzag design connected with a continuous single weld in each 3mm segments. It scores over excellent trackability and optimum radio-opacity. Therefore, it is easy to operate and feasible in tortuous, distal lesions and variety of lesion lengths. We report our experiences with Micro-II stent implanatation in the first 76 patients at Tonsei cardiovascular center to assess its safety and efficacy in patients with complex coronary anatomy and clinical results in the first months. METHODS: Between January 1996 and July 1996, eighty-six Micro-II stent were implanted in the coronary arteries of 76 patients(male 65.8%, age 59+/-10 year). Forty-five patients had unstable angina, the others had stable angina(17pts), acute myocardial infarction(14pts). RESULTS: 1) Indication of stenting was de novo 51(59.3%), suboptimal result 25(29.1%), restenosis 1(1.2%) and 9(10.4%) of lesions were stented in bail out situation. 2) Single stent were implanted in 76(88.4%)lesions, overlapping stent in 10(11.6%)lesions. Among overlapping stents, the second stent with Micro-II stent and with another kind of stent were 4.6%, 7.0%, respectively. 3) Procedure related complication including a subacute closure was occurred in 1(1.2%) patient who had distal dissection and 45% residual stenosis. In 12(14%) lesions, preistent dissection has been noticed after stent impantation. 4) Angiographic success(defined as a residual stenosis of <30% without major dissection) was achieved in 82 of 86 attempts(95.3%). The procedual success rate(defined as a residual stenosis of <30% without occurrence of major clinical events within 4 weeks after procesure) was 96.1%(73/76 patients). Angiographic success and procedural success rate in calcified lesion were 100% and 100%, respectively. Angiographic success and procedural success rate in more than 45` angulated lesion were 97% and 100%, respectively. 5) The mean minimal luminal diameter of the target lesions was increased from 0.42+/-0.40mm before stent implantation to 2.93+/-0.50mm(p<0.001). The percentage of diameter stenosis was reduced from 86.49+/-13.04% to 1.40+/-7.11%(p<0.001) after stent implantation. CONCLUSION: Coronary stenting with AVE Micro-II stent can be safety performed and is particularly beneficial in tortuous and calcified arteries. There was a high tendency for peristent dissection which need to special consideration to avoid. Follow-up data is needed to assess mid and term patency. Coronary artery disease . AVE Micro-II stent . Immediate results.
Angina, Unstable
;
Angioplasty, Balloon
;
Arteries
;
Constriction, Pathologic
;
Coronary Artery Disease
;
Coronary Vessels
;
Follow-Up Studies
;
Humans
;
Phenobarbital
;
Stainless Steel
;
Stents*
7.Effects of Anterior Temporal Lobectomy for Mesial Temporal Lobe Epilepsy on Intellectual and Memory Functions: 1-Year Follow-up.
Hongkeun KIM ; Sangdoe YI ; Eun Ik SON ; Jieun KIM
Journal of the Korean Neurological Association 2006;24(4):347-355
BACKGROUND: The aim of this study was to identify factors predicting intellectual and memory changes following anterior temporal lobectomy (ATL) for mesial temporal lobe epilepsy (TLE). METHODS: The sample consisted of 31 patients who underwent ATL for treatment of medically intractable TLE. All patients were administered intellectual and memory tests preoperatively and postoperatively. RESULTS: All statistically significant intellectual and memory changes at 1-year follow-up were in the direction of improvement. Left vs. right ATL had significantly differential effects on verbal intelligence and verbal memory, reflecting greater decline (or less improvement) following a left ATL. A later onset age of seizures, an older age at surgery, and a higher presurgical cognitive performance predicted a greater cognitive decline following an ATL. CONCLUSIONS: At 1-year after ATL, most cognitive functions showed either no significant changes or significant changes in a favorable direction. Decreased verbal functions following a left ATL was the area of greatest potential neuropsychological morbidity associated with ATL. Greater cognitive decline following ATL was predicted by later onset age of recurrent seizures, older age at time of surgery, and higher presurgical cognitive performance.
Age of Onset
;
Anterior Temporal Lobectomy*
;
Epilepsy, Temporal Lobe*
;
Follow-Up Studies*
;
Humans
;
Intelligence
;
Memory*
;
Seizures
;
Temporal Lobe*
8.Microbubbles used for contrast enhanced ultrasound and theragnosis: a review of principles to applications.
Hohyeon LEE ; Haemin KIM ; Hyounkoo HAN ; Minji LEE ; Sunho LEE ; Hongkeun YOO ; Jin Ho CHANG ; Hyuncheol KIM
Biomedical Engineering Letters 2017;7(2):59-69
Ultrasound was developed several decades ago as a useful imaging modality, and it became the second most popular diagnostic tool due to its non-invasiveness, real-time capabilities, and safety. Additionally, ultrasound has been used as a therapeutic tool with several therapeutic agents and in nanomedicine. Ultrasound imaging is often used to diagnose many types of cancers, including breast, stomach, and thyroid cancers. In addition, ultrasound-mediated therapy is used in cases of joint inflammation, rheumatoid arthritis, and osteoarthritis. Microbubbles, when used as ultrasound contrast agents, can act as echo-enhancers and therapeutic agents, and they can play an essential role in ultrasound imaging and ultrasound-mediated therapy. Recently, various types of ultrasound contrast agents made of lipid, polymer, and protein shells have been used. Air, nitrogen, and perfluorocarbon are usually included in the core of the microbubbles to enhance ultrasound imaging, and therapeutic drugs are conjugated and loaded onto the surface or into the core of the microbubbles, depending on the purpose and properties of the substance. Many research groups have utilized ultrasound contrast agents to enhance the imaging signal in blood vessels or tissues and to overcome the blood–brain barrier or blood-retina barrier. These agents are also used to help treat diseases in various regions or systems of the body, such as the cardiovascular system, or as a cancer treatment. In addition, with the introduction of targeted moiety and multiple functional groups, ultrasound contrast agents are expected to have a potential future in ultrasound imaging and therapy. In this paper, we briefly review the principles of ultrasound and introduce the underlying theory, applications, limitations, and future perspectives of ultrasound contrast agents.
Arthritis, Rheumatoid
;
Blood Vessels
;
Breast
;
Cardiovascular System
;
Contrast Media
;
Inflammation
;
Joints
;
Microbubbles*
;
Nanomedicine
;
Nitrogen
;
Osteoarthritis
;
Polymers
;
Stomach
;
Thyroid Neoplasms
;
Ultrasonography*
9.Successful rapid desensitization to trimethoprim-sulfamethoxazole-induced delayed hypersensitivity.
Doran YOON ; Hongkeun AHN ; Se Yong KIM ; Seong Jun HWANG ; Han Ki PARK ; Hye Ryun KANG
Allergy, Asthma & Respiratory Disease 2015;3(2):155-158
Trimethoprim-sulfamethoxazole (TMP-SMX) is an antibiotic used for the treatment or prophylaxis of Pneumocystis pneumonia and other infectious conditions. Sulfonamide derivatives have been reported to cause delayed hypersensitivity reactions, resulting in switch to less effective second-line antibiotics. Although desensitization is traditionally known to be effective in patients with immediate hypersensitivity, it is also applied to the treatment of delayed hypersensitivity in recent years. A 66-year-old female who had a history of repeated TMP-SMX-induced delayed hypersensitivity presenting as whole body rashes needed to take prophylactic dose of TMP-SMX (80/400 mg daily) before initiation of chemotherapy for multiple myeloma. Intravenous rapid desensitization was performed by using a 11-step, 4-bottle protocol from 1:1,000 to 1:1 solution for 3 hours to reach the target dose for prophylaxis. After successful rapid desensitization of TMP-SMX, 1-month prophylaxis was completed without any complications until the patient recovered normal immunity. We herein reported a case of delayed hypersensitivity reaction to TMP-SMX in an about-to-be immunocompromised host with planned chemotherapy who successfully completed 1-month prophylaxis with the drug without any complications through rapid desensitization.
Aged
;
Anti-Bacterial Agents
;
Desensitization, Immunologic
;
Drug Therapy
;
Exanthema
;
Female
;
Humans
;
Hypersensitivity, Delayed*
;
Hypersensitivity, Immediate
;
Immunocompromised Host
;
Multiple Myeloma
;
Pneumonia, Pneumocystis
;
Sulfamethoxazole
;
Trimethoprim
;
Trimethoprim, Sulfamethoxazole Drug Combination